{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:07:54Z","timestamp":1784092074210,"version":"3.55.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Re-recurrent rectal cancer (RRRC) represents a highly complex disease following curative-intent treatment of recurrent rectal cancer (RRC). While management principles for primary and locally recurrent rectal cancer (RRC) have been defined by expert collaborations, no specific guidelines currently outline the perioperative management of RRRC. This systematic review aimed to appraise the reported perioperative strategies and oncological outcomes of patients undergoing curative-intent treatment for RRRC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Eligibility criteria, Studies reporting perioperative management and outcomes of adult patients undergoing curative-intent treatment for RRRC were included. Non-English articles, letters, abstracts, and studies lacking surgical or oncological data were excluded. Information sources, The review was conducted according to PRISMA guidelines and registered in PROSPERO (CRD420251244390). MEDLINE (PubMed), Cochrane Library, Web of Science, and Scopus were searched for relevant articles. Risk of bias, Methodological quality was assessed using the Newcastle\u2013Ottawa Scale for cohort studies. Synthesis of results, Given heterogeneity in treatment strategies and outcome reporting, results were synthesized narratively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Included studies, Three retrospective cohort studies comprising 169 patients treated with curative intent surgery for RRRC were included. Synthesis of results, Neoadjuvant therapy was administered in 20\u201392% of included patients, depending on the previous cumulative radiation dose. Pelvic exenteration was frequently required, with total exenteration performed in 6\u201320% and sacrectomy in up to 15% of cases; reconstructive procedures were reported in less than 16%. IORT was used in 44\u201377% of patients in centers where it was available. R0 resection rates ranged from 33% to 62%, with oncological outcomes directly associated with margin status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Limitations of evidence, Evidence was limited to retrospective observational studies with small sample sizes, heterogeneous management, and varied institutional resources, precluding meta-analysis. Interpretation, Curative-intent surgery for RRRC is feasible in highly selected patients, with R0 being the principal prognostic determinant of oncological outcome. However, significant variability in perioperative pathways, margin definition, MRI-based classification, and reconstructive strategies underlines the necessity for the development of standardized, consensus-based recommendations to optimize multidisciplinary treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251244390<\/jats:ext-link>\n                      , identifier CRD420251244390.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1867185","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:40:36Z","timestamp":1784090436000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Current evidence on the management of re-recurrent rectal cancer: a systematic review"],"prefix":"10.3389","volume":"16","author":[{"given":"Georgios","family":"Giannos","sequence":"first","affiliation":[{"name":"2nd Surgical Department, Hygeia Hospital","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Theodoropoulos","sequence":"additional","affiliation":[{"name":"2nd Surgical Department, Hygeia Hospital","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximos","family":"Frountzas","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Royal Marsden Hospital","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Royal Marsden Hospital","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Katsigeorgis","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Department of Surgery, NYU Grossman School of Medicine, NYU Langone Health","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia Y.","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Department of Surgery, NYU Grossman School of Medicine, NYU Langone Health","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahnawaz","family":"Rasheed","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Royal Marsden Hospital","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paris","family":"Tekkis","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Royal Marsden Hospital","place":["London, United Kingdom"]},{"name":"Department of Surgery and Cancer, Imperial College","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar","family":"Safar","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Department of Surgery, NYU Grossman School of Medicine, NYU Langone Health","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Kontovounisios","sequence":"additional","affiliation":[{"name":"2nd Surgical Department, Hygeia Hospital","place":["Athens, Greece"]},{"name":"Department of Colorectal Surgery, Royal Marsden Hospital","place":["London, United Kingdom"]},{"name":"Division of Colon and Rectal Surgery, Department of Surgery, NYU Grossman School of Medicine, NYU Langone Health","place":["New York, NY, United States"]},{"name":"Department of Surgery and Cancer, Imperial College","place":["London, United Kingdom"]},{"name":"Department of Colorectal Surgery, Chelsea and Westminster Hospital","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70043","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA A Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-13141-y","article-title":"Locally recurrent rectal cancer: Toward a second chance at cure? A population-based, retrospective cohort study","volume":"30","author":"Swartjes","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.110261","article-title":"Treatment and outcomes of local re-recurrence in rectal cancer: a multicentre observational cohort","volume":"51","author":"Creemers","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9192","article-title":"Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes","volume":"100","author":"Ali","year":"2013","journal-title":"Br J Surg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13051228","article-title":"Re-do plastic reconstruction for locally advanced and recurrent colorectal cancer following a beyond total mesorectal excision (TME) operation\u2014key considerations","volume":"13","author":"Giannas","year":"2024","journal-title":"JCM"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3647\u2013","DOI":"10.1200\/jco.2010.28.15_suppl.3647","article-title":"Multimodal salvage therapy for locally recurrent and re-recurrent rectal cancer","volume":"28","author":"You","year":"2010","journal-title":"JCO"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.8991","article-title":"Outcome of surgical resection of second-time locally recurrent rectal cancer","volume":"100","author":"Harji","year":"2013","journal-title":"J Br Surg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0b013e3182741929","article-title":"Is curative resection and long-term survival possible for locally re-recurrent colorectal cancer in the pelvis","volume":"56","author":"Colibaseanu","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-004-0909-0","article-title":"Surgery for locally recurrent rectal cancer","volume":"48","author":"Boyle","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110520","article-title":"Analysis of re-recurrent rectal cancer after curative treatment of locally recurrent rectal cancer","volume":"200","author":"Piqeur","year":"2024","journal-title":"Radiotherapy Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2025.100934","article-title":"Prospective radiotherapy quality assurance leads to delineation guideline refinements for recurrent rectal cancer: Experience from the PelvEx II study","volume":"52","author":"Piqeur","year":"2025","journal-title":"Clin Trans Radiat Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-016-0752-1","article-title":"Intraoperative radiation therapy for colon and rectal cancers: a clinical review","volume":"12","author":"Haddock","year":"2017","journal-title":"Radiat Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2022.06.015","article-title":"Minimum radial margin in pelvic exenteration for locally advanced or recurrent rectal cancer","volume":"48","author":"Aiba","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrab024","article-title":"Systematic review of classification systems for locally recurrent rectal cancer","volume":"5","author":"Rokan","year":"2021","journal-title":"BJS Open"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11123511","article-title":"Locally recurrent rectal cancer according to a standardized MRI classification system: A systematic review of the literature","volume":"11","author":"Rokan","year":"2022","journal-title":"JCM"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/codi.16476","article-title":"The 'Pelvic exenteration lexicon\u2019: Creating a common language for complex pelvic cancer surgery","volume":"25","author":"Burns","year":"2023","journal-title":"Colorectal Dis"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1867185\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:40:42Z","timestamp":1784090442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1867185\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":19,"alternative-id":["10.3389\/fonc.2026.1867185"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1867185","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1867185"}}